Worldwide 3D Cell Culture Industry to 2027 - Advantages of 3D Culture Techniques Over 2D Techniques is Driving Growth

Dublin, Feb. 09, 2021 (GLOBE NEWSWIRE) -- The "3D Cell Culture Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2020-2027" report has been added to ResearchAndMarkets.com's offering.

Cell culture is a significant tool in biological research. These cultures are mainly of two types, namely two-dimensional (2D) and three-dimensional (3D). Since the advent of cell culture techniques, 2D cell cultures are mostly preferred due to their availability, ease of environmental control, cell observation and measurement. However, growing cells in flat layers on surfaces do not precisely model the in-vivo state.

As compared to 2D, 3D cell culture permits the biological cells to grow and interact with their surroundings in all three dimensions. Cells grown in a 3D cell culture models have proven to be physiologically relevant. They have shown improvements in numerous studies of biological mechanisms including cell morphology, proliferation, differentiation, cell number monitoring, viability, migration & invasion of tumor cells into surrounding tissues, response to stimuli, angiogenesis stimulation, drug metabolism, gene expression & protein synthesis, immune system evasion, and in-vivo relevance. Thus, 3D cell cultures are beneficial in studying and analyzing the etiology of diseases; thereby, facilitating their adoption in the field of research.

The global 3D cell culture market was evaluated at $1,234. 86 million in 2019, and is estimated to garner $3,721. 68 million by 2027, registering a CAGR of 16. 3% during the forecast period. This growth rate is majorly attributed to the advantages offered by 3D cell cultures over conventional 2D cell cultures in cell-to-cell and cell-to-matrix interactions. In addition, continuous effort in R&D activities for drug discovery, development & screening and inclination toward the use of 3D cell cultures in cancer research are some other factors anticipated to propel the growth of the market over the analysis period. Likewise, surge in demand for organ transplantation is predicted to have a positive impact on the growth of 3D cell culture market. Conversely, higher costs associated with implementation of 3D cell cultures and inconsistent results are obstructing the market growth.

On the other hand, upcoming technologies leading to product advancements in the field of 3D cell culture is estimated to provide profitable growth opportunities for the key market players in the market. Furthermore, the 3D cell culture industry is currently facing newer challenges to cope up with the demand and supply of 3D cell culture components owing to the COVID-19 pandemic. In addition, inconsistent and interrupted supply chain activities and availability of human resources are expected to impact the market growth. On the contrary, surge in research practices for developing novel therapies against COVID-19 is serving as a huge opportunity for the key market players. Research associated with stem cell therapies and regenerative medicine has shown promising results for treating the COVID-19 disease; thus, this is expected to compensate the deleterious impact caused by lockdowns globally. Thus, the overall COVID-19 impact is anticipated to remain moderate for the prominent players in the 3D cell culture market.

The research report categorizes the 3D cell culture market based on product, application, end user, and region. Based on product, the market is segmented into scaffold-based platforms, scaffold-free platforms, gels, bioreactors, microchips and services. Based on application, the 3D cell culture market is divided into cancer research, stem cell research, drug discovery, and regenerative medicine. The end user segment of the market comprises biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. Region wise, the market has been analyzed across four regions namely, North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

• This report provides a detailed quantitative analysis of the current market trends and future estimations from 2019 to 2027, which assists to identify the prevailing market opportunities.

• An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.

• A comprehensive analysis of the factors that drive and restrain the growth of the global 3D cell culture market is provided.

• An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

Key Topics Covered:

Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models

Chapter 2: Executive Summary
2.1. Cxo Perspective

Chapter 3: Market Overview
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Patent Analysis
3.3.1. Patent Analysis, by Year
3.3.2. Patent Analysis, by Country
3.4. Market Dynamics
3.4.1. Drivers
3.4.1.1. Advantages of 3D Culture Techniques Over 2D Techniques
3.4.1.2. Growth in Investments Toward R&D Activities
3.4.1.3. Shift in Preference Toward 3D Cell Cultures for Cancer Research
3.4.1.4. Upsurge in Demand for Organ Transplantation
3.4.2. Restraints
3.4.2.1. Higher Implementation Costs
3.4.2.2. Irregularity in 3D Cell Culture Outcomes
3.4.3. Opportunity
3.4.3.1. Technological Advancements
3.5. Covid-19 Impact Analysis

Chapter 4: 3D Cell Culture Market, by Product
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Scaffold-Based Platform
4.2.1. Key Market Trends and Growth Opportunities
4.2.2. Market Size and Forecast
4.2.3. Market Analysis, by Country
4.2.4. Scaffold-Based Platform Market, by Type
4.2.4.1. Macro-Porous Scaffolds
4.2.4.1.1. Market Size and Forecast
4.2.4.2. Micro-Porous Scaffolds
4.2.4.2.1. Market Size and Forecast
4.2.4.3. Nano-Porous Scaffolds
4.2.4.3.1. Market Size and Forecast
4.2.4.4. Solid Scaffolds
4.2.4.4.1. Market Size and Forecast
4.3. Scaffold-Free Platform
4.3.1. Key Market Trends and Growth Opportunities
4.3.2. Market Size and Forecast
4.3.3. Market Analysis, by Country
4.4. Gels
4.4.1. Key Market Trends and Growth Opportunities
4.4.2. Market Size and Forecast
4.4.3. Market Analysis, by Country
4.5. Bioreactors
4.5.1. Key Market Trends and Growth Opportunities
4.5.2. Market Size and Forecast
4.5.3. Market Analysis, by Country
4.6. Microchips
4.6.1. Key Market Trends and Growth Opportunities
4.6.2. Market Size and Forecast
4.6.3. Market Analysis, by Country
4.7. Services
4.7.1. Key Market Trends and Growth Opportunities
4.7.2. Market Size and Forecast
4.7.3. Market Analysis, by Country

Chapter 5: 3D Cell Culture Market, by Application
5.1. Overview
5.1.1. Market Size and Forecast
5.2. Cancer Research
5.2.1. Market Size and Forecast
5.2.2. Market Analysis, by Country
5.3. Stem Cell Research
5.3.1. Market Size and Forecast
5.3.2. Market Analysis, by Country
5.4. Drug Discovery
5.4.1. Market Size and Forecast
5.4.2. Market Analysis, by Country
5.5. Regenerative Medicine
5.5.1. Market Size and Forecast
5.5.2. Market Analysis, by Country

Chapter 6: 3D Cell Culture Market, by End-user
6.1. Overview
6.1.1. Market Size and Forecast
6.2. Biotechnology & Pharmaceutical Companies
6.2.1. Market Size and Forecast
6.2.2. Market Analysis, by Country
6.3. Contract Research Laboratories
6.3.1. Market Size and Forecast
6.3.2. Market Analysis, by Country
6.4. Academic Institutes
6.4.1. Market Size and Forecast
6.4.2. Market Analysis, by Country

Chapter 7: 3D Cell Culture Market, by Region
7.1. Overview
7.2. North America
7.3. Europe
7.4. Asia-Pacific
7.5. LAMEA

Chapter 8: Company Profiles
8.1.3D Biotek LLC
8.1.1. Company Overview
8.1.2. Company Snapshot
8.1.3. Operating Business Segments
8.1.4. Business Performance
8.2. Advanced Biomatrix, Inc.
8.2.1. Company Overview
8.2.2. Company Snapshot
8.2.3. Operating Business Segments
8.2.4. Business Performance
8.2.5. Key Strategic Moves and Developments
8.3. Avantor, Inc.
8.3.1. Company Overview
8.3.2. Company Snapshot
8.3.3. Operating Business Segments
8.3.4. Business Performance
8.4. Becton, Dickinson and Company
8.4.1. Company Overview
8.4.2. Company Snapshot
8.4.3. Operating Business Segments
8.4.4. Business Performance
8.5. Corning Incorporated
8.5.1. Company Overview
8.5.2. Company Snapshot
8.5.3. Operating Business Segments
8.5.4. Business Performance
8.5.5. Key Strategic Moves and Developments
8.6. Insphero AG
8.6.1. Company Overview
8.6.2. Company Snapshot
8.6.3. Operating Business Segments
8.6.4. Business Performance
8.6.5. Key Strategic Moves and Developments
8.7. Lonza Group Ltd.
8.7.1. Company Overview
8.7.2. Company Snapshot
8.7.3. Operating Business Segments
8.7.4. Business Performance
8.7.5. Key Strategic Moves and Developments
8.8. Merck & Co. Inc.
8.8.1. Company Overview
8.8.2. Company Snapshot
8.8.3. Operating Business Segments
8.8.4. Business Performance
8.9. Synthecon, Incorporated
8.9.1. Company Overview
8.9.2. Company Snapshot
8.9.3. Business Performance
8.10. Thermo Fisher Scientific Inc.
8.10.1. Company Overview
8.10.2. Company Snapshot
8.10.3. Operating Business Segments
8.10.4. Business Performance

For more information about this report visit https://www.researchandmarkets.com/r/oa1aoj

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900